CALDARA, ALESSIA
 Distribuzione geografica
Continente #
AS - Asia 160
EU - Europa 145
NA - Nord America 110
SA - Sud America 15
AF - Africa 5
Totale 435
Nazione #
US - Stati Uniti d'America 105
DE - Germania 65
SG - Singapore 61
CN - Cina 35
IT - Italia 29
BD - Bangladesh 17
HK - Hong Kong 12
RU - Federazione Russa 12
GB - Regno Unito 11
VN - Vietnam 10
FR - Francia 8
BR - Brasile 7
NL - Olanda 7
IN - India 6
JP - Giappone 5
ID - Indonesia 4
CO - Colombia 3
EC - Ecuador 3
IE - Irlanda 3
IQ - Iraq 3
SE - Svezia 3
AE - Emirati Arabi Uniti 2
CI - Costa d'Avorio 2
FI - Finlandia 2
TR - Turchia 2
AR - Argentina 1
BB - Barbados 1
BG - Bulgaria 1
CA - Canada 1
CG - Congo 1
JO - Giordania 1
KR - Corea 1
MA - Marocco 1
MX - Messico 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UA - Ucraina 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 435
Città #
Frankfurt am Main 60
Singapore 28
Ashburn 14
Dallas 12
Hong Kong 10
San Jose 10
Beijing 9
Southend 9
Santa Clara 7
Rome 6
Council Bluffs 5
Bengaluru 4
Boardman 4
Buffalo 4
Hefei 4
Ho Chi Minh City 4
Lauterbourg 4
Los Angeles 4
Moscow 4
Munich 4
New York 4
Chandler 3
Dublin 3
Morioka 3
São Paulo 3
Abidjan 2
Bari 2
Denver 2
Hanoi 2
Indianapolis 2
Istanbul 2
Jakarta 2
Naples 2
Princeton 2
Quito 2
San Francisco 2
Tokyo 2
Abu Dhabi 1
Amman 1
Arzachena 1
Atlanta 1
Beloslav 1
Biên Hòa 1
Bogotá 1
Bridgetown 1
Candeias 1
Caracas 1
Clinton 1
Columbus 1
Cota 1
Des Moines 1
Duhok 1
Espoo 1
Ferraz de Vasconcelos 1
Foggia 1
Guangzhou 1
Guayaquil 1
Hadley 1
Houston 1
Hyderabad 1
Jiaxing 1
Johannesburg 1
Juiz de Fora 1
Kirkuk 1
Kropyvnytskyi 1
Libertad 1
Lisbon 1
Miami 1
Milan 1
Mérida 1
Nanchang 1
Nizhnekamsk 1
Nuremberg 1
Ontario 1
Oslo 1
Pasadena 1
Port of Spain 1
Portsmouth 1
Pune 1
Quận Bình Thạnh 1
Ras al-Khaimah 1
Rho 1
Salt Lake City 1
San Salvador 1
Shijiazhuang 1
São Lourenço 1
Thái Bình 1
Toronto 1
Turku 1
Tây Ninh 1
Villavicencio 1
Warsaw 1
Washington 1
Wilmington 1
Xiamen 1
Yongin-si 1
Zakho 1
Totale 306
Nome #
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer 197
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 137
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 73
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer 50
Correction to: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer (npj Breast Cancer, (2023), 9, 1, (73), 10.1038/s41523-023-00579-2) 1
Totale 458
Categoria #
all - tutte 1.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.323


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 2 0 0 0 1 0 0 0 0 0 0 3
2022/202322 1 0 3 2 2 2 0 0 2 4 5 1
2023/202457 0 1 0 5 7 2 8 6 5 6 10 7
2024/2025102 7 17 6 12 12 3 0 5 3 9 4 24
2025/2026250 14 11 45 15 26 13 20 7 25 19 19 36
Totale 458